DDInter608 DDInter381
Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor.[label] It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686. Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder. It has since received approval for a variety of indications including the treatment of neuropathic pain, Generalized Anxiety disorder, osteoarthritis, and stress incontinence. Duloxetine continues to be investigated for the treatment of pain in cancer, surgery, and more.
Cinacalcet is a calcimimetic sold by Amgen under the trade name Sensipar® in North America and Australia and as Mimpara® in Europe. It is used to treat hyperparathyroidism due to parathyroid tumours or renal failure.
Duloxetine {u} (Compound) resembles {v} (Compound) Cinacalcet
Duloxetine {u} (Compound) resembles {v} (Compound) Propranolol
Propranolol {u} (Compound) resembles {v} (Compound) Cinacalcet
Duloxetine {u} (Compound) resembles {v} (Compound) Fluoxetine
Fluoxetine {u} (Compound) resembles {v} (Compound) Cinacalcet
Duloxetine {u} may lead to a major life threatening interaction when taken with {v} Dexfenfluramine
Dexfenfluramine {u} (Compound) resembles {v} (Compound) Cinacalcet
Duloxetine {u} (Compound) binds {v} (Gene) CYP1A2
CYP1A2 {u} (Gene) is bound by {v} (Compound) Cinacalcet
Duloxetine {u} (Compound) causes {v} (Side Effect) Dyspepsia
Dyspepsia {u} (Side Effect) is caused by {v} (Compound) Cinacalcet
Duloxetine {u} (Compound) resembles {v} (Compound) Propranolol
Propranolol {u} (Compound) resembles {v} (Compound) Demexiptiline
Demexiptiline {u} (Compound) resembles {v} (Compound) Cinacalcet
Duloxetine {u} (Compound) resembles {v} (Compound) Naftifine
Naftifine {u} (Compound) resembles {v} (Compound) Butenafine
Butenafine {u} (Compound) resembles {v} (Compound) Cinacalcet
Duloxetine {u} may lead to a major life threatening interaction when taken with {v} Dexfenfluramine
Dexfenfluramine {u} may lead to a major life threatening interaction when taken with {v} Fluoxetine
Fluoxetine {u} (Compound) resembles {v} (Compound) Cinacalcet
Duloxetine {u} (Compound) binds {v} (Gene) CYP1A2
CYP1A2 {u} (Gene) is bound by {v} (Compound) Propranolol
Propranolol {u} (Compound) resembles {v} (Compound) Cinacalcet
Duloxetine (Compound) resembles Cinacalcet (Compound)
Duloxetine (Compound) resembles Propranolol (Compound) and Propranolol (Compound) resembles Cinacalcet (Compound)
Duloxetine (Compound) resembles Fluoxetine (Compound) and Fluoxetine (Compound) resembles Cinacalcet (Compound)
Duloxetine may lead to a major life threatening interaction when taken with Dexfenfluramine and Dexfenfluramine (Compound) resembles Cinacalcet (Compound)
Duloxetine (Compound) binds CYP1A2 (Gene) and CYP1A2 (Gene) is bound by Cinacalcet (Compound)
Duloxetine (Compound) causes Dyspepsia (Side Effect) and Dyspepsia (Side Effect) is caused by Cinacalcet (Compound)
Duloxetine (Compound) resembles Propranolol (Compound) and Propranolol (Compound) resembles Demexiptiline (Compound) and Demexiptiline (Compound) resembles Cinacalcet (Compound)
Duloxetine (Compound) resembles Naftifine (Compound) and Naftifine (Compound) resembles Butenafine (Compound) and Butenafine (Compound) resembles Cinacalcet (Compound)
Duloxetine may lead to a major life threatening interaction when taken with Dexfenfluramine and Dexfenfluramine may lead to a major life threatening interaction when taken with Fluoxetine and Fluoxetine (Compound) resembles Cinacalcet (Compound)
Duloxetine (Compound) binds CYP1A2 (Gene) and CYP1A2 (Gene) is bound by Propranolol (Compound) and Propranolol (Compound) resembles Cinacalcet (Compound)